Furthermore, it is found that EDAR expression is significantly greater in patients with nonrecurrent NPC than in those with recurrent disease and that EDAR expression is positively correlated with CD8+ T‐cell infiltration; thus, it may be a potential biomarker for NPC prognosis. The gene discussed is EDAR; the disease is nasopharyngeal carcinoma.